Case report: One pediatric liver-transplant recipient with SARS-CoV-2 infection suffering unexplained mixed acidosis
BackgroundThe management of LT patients during COVID-19 pandemic is important. Immunosuppressants (IS) are key therapy agents after liver transplant. Different ISs have different side effects. Calcineurin inhibitor (CNI) may lead to metabolic acidosis while mycophenolate mofetil (MMF) showed rare ne...
Main Authors: | Lianhu Yu, Lu Zheng, Hui Hu, Ping Wan, Yanming Lu, Libo Wang, Hui Yu, Yiwei Chen, Jianguo Zhou, Qiang Xia, Wenhao Zhou, Ting Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.972978/full |
Similar Items
-
Mediastinal tuberculous abscess: A rare presentation after renal transplant
by: Sukanto K Das, et al.
Published: (2019-01-01) -
A comprehensive review of immunosuppressive drugs in pediatric dermatoses: Part II – methotrexate and mycophenolate mofetil
by: Shiti Bose, et al.
Published: (2022-01-01) -
Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review
by: Alice Tung Wan Song, et al. -
Mycophenolate Mofetil;A Review of Indications and Use in a Large Tertiary Hospital
by: Nimeshan Geevasinga, et al.
Published: (2005-12-01) -
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies
by: C Bandelier
Published: (2009-01-01)